Flow Cytometry Market is valued at USD 6.3 Billion in 2020 and expected to reach USD 10.57 Billion by 2026 with a CAGR of 9% over the forecast period. Rise in adoption of flowcytometry technique in research, advancement in diagnostic technologies in flow cytometry, increasing prevalence of chronic diseases, growth in demand of flocytometry in immunological research, growth in adoption of clinical trials these are some factors which drives the growth of the global Flow Cytometry Market.
Flow Cytometry Market Key Players: • • • • • • • • • • • • • • • • •
Becton Dickinson and Company Beckman Coulter Inc. Thermo Fisher Scientific Inc. Merck KGaA Sysmex Partec GmbH Luminex Corporation Miltenyi Biotec GmbH Bio-Rad Laboratories Inc. Sony Biotechnology Inc. Agilent Technologies Inc. bioMérieux S.A. Enzo Life Sciences Inc. Stratedigm Inc. Cytonome/ST LLC Cytek Biosciences Apogee Flow Systems Ltd. others.
Global Flow Cytometry Market Segmentation: Type • • • •
Instrument Kit Reagents Software
Applications •
Drug discovery
• •
Disease diagnosis, Stem cell therapy.
End users • • •
Hospitals and clinics, Biotechnology companies Research institutes.
On Special Requirement Flow Cytometry Market Report is also available for below Regions and Country:
North America • •
U.S. Canada
Europe • • • • • • • • • • •
Germany France U.K. Italy Spain Sweden Netherland Turkey Switzerland Belgium Rest of Europe
Asia-Pacific • • • • • • • • • •
South Korea Japan China India Australia Philippines Singapore Malaysia Thailand Indonesia
•
Rest Of APAC
Latin America • • • • • •
Mexico Colombia Brazil Argentina Peru Rest of South America
Middle East and Africa • • • • •
Saudi Arabia UAE Egypt South Africa Rest Of MEA